Key Takeaways
- • Elaine Stead serves as Managing Director of Venture Capital at Blue Sky, overseeing a venture capital division established in 2012 with over $100 million in assets under management across multiple industry sectors.
- • Blue Sky's venture capital platform operates dual funds—the original fund and VC2014—with diversified exposure spanning agriculture, healthcare, and information technology sectors.
- • Stead brings dual expertise combining scientific credentials (PhD in biochemistry from University of Adelaide) with a decade of venture capital and management consulting experience across Australia and the United States.
- • As an active member of the Australian Venture Capital Association's stakeholder committee and the investment committee of ANUConnect Venture Capital (Australian National University's fund), Stead operates at senior levels of Australia's venture capital ecosystem.
- • Her background spans technology commercialization, strategic management consulting with NASDAQ and ASX-listed companies, and early-stage founder support across multiple sectors.
Summary
Elaine Stead holds the position of Managing Director of Venture Capital at Blue Sky, where she oversees the management of the firm's venture capital fund and portfolio. The venture capital division, established in 2012, has evolved into a multi-fund platform comprising the original fund and VC2014, collectively managing over $100 million in assets across a diverse range of industry sectors including agriculture, healthcare, and information technology.
Stead's professional background combines scientific training with extensive venture capital experience. Originally trained as a stem cell biologist, she holds a PhD in biochemistry from the University of Adelaide. Over the past decade, she has transitioned from academic science into the innovation and investment space, initially focusing on technology commercialization work that assisted public institutions and founders in translating and commercializing innovations across multiple sectors.
Her career trajectory includes roles as a venture capitalist and management consultant serving the venture and innovation sectors in both Australia and the United States. She has also worked in strategic management consulting with both NASDAQ and ASX-listed companies as well as private enterprises based in Australia and the United States, providing her with extensive operational and capital markets exposure across different markets and company stages.
Within Australia's venture capital community, Stead maintains active involvement at the institutional level. She serves as a committee member of the Australian Venture Capital Association Ltd (AVCAL) and sits on the investment committee of ANUConnect Venture Capital, the venture capital fund of the Australian National University. These positions reflect her standing within the professional venture capital ecosystem and her influence on capital allocation decisions within the Australian innovation sector.
Stead's professional background combines scientific training with extensive venture capital experience. Originally trained as a stem cell biologist, she holds a PhD in biochemistry from the University of Adelaide. Over the past decade, she has transitioned from academic science into the innovation and investment space, initially focusing on technology commercialization work that assisted public institutions and founders in translating and commercializing innovations across multiple sectors.
Her career trajectory includes roles as a venture capitalist and management consultant serving the venture and innovation sectors in both Australia and the United States. She has also worked in strategic management consulting with both NASDAQ and ASX-listed companies as well as private enterprises based in Australia and the United States, providing her with extensive operational and capital markets exposure across different markets and company stages.
Within Australia's venture capital community, Stead maintains active involvement at the institutional level. She serves as a committee member of the Australian Venture Capital Association Ltd (AVCAL) and sits on the investment committee of ANUConnect Venture Capital, the venture capital fund of the Australian National University. These positions reflect her standing within the professional venture capital ecosystem and her influence on capital allocation decisions within the Australian innovation sector.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.